There may be good news for men who experience a recurrence of prostate cancer following surgery for the disease.
U.S. researchers say radiation therapy, if administered within two years of a recurrence of prostate cancer following surgery, can greatly reduce the risk of death.
Researchers at Johns Hopkins University School of Medicine in Baltimore studied the medical records of 635 men in the United States who underwent the same surgery for prostate cancer, only to see the cancer return later.
Out of the 635 men, 397 did not receive additional therapy, 160 underwent radiation therapy, and 78 had both radiation and hormonal therapy. The researchers found that the men who received radiation therapy had an 86% chance of surviving 10 years. The men who did not undergo radiation therapy had a 62% chance.
The study was published in the Journal of the American Medical Association. Researchers are now working on tests to help identify factors that contribute to a recurrence of prostate cancer following surgery.